跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 12,369 条关于
“muscarinic M1 receptor”
全部
12,369
临床试验
5,951
药物
1,351
机构
30
资讯
5,037
23天前
FDA Clears IND for Neurocrine and Nxera's Oral M1 Agonist NBI-1117567 in Alzheimer's Cognition
去年
AbbVie's Schizophrenia Drug Fails in Phase 3 Trials, Stock Price Drops
2个月前
First In Vivo PET Evidence Reveals Widespread M1 Receptor Deficits in Living Schizophrenia Patients
去年
FDA Approves Cobenfy, a Novel Muscarinic Receptor-Targeting Drug for Schizophrenia
前天
J&J's M1 Antagonist PIPE-307 Misses Primary Endpoint in Phase 2 MDD Trial, Second Setback for the Molecule
去年
AbbVie's Emraclidine Fails to Meet Endpoints in Phase 2 Schizophrenia Trials
去年
FDA Approves Cobenfy, a Novel Schizophrenia Treatment Targeting Cholinergic Receptors
去年
Tonix Pharmaceuticals Submits NDA for TNX-102 SL in Fibromyalgia
去年
Tonix Pharmaceuticals' TNX-102 SL Shows Promise in Fibromyalgia Treatment
去年
MapLight Therapeutics Initiates Phase 2 Trial of Novel M1/M4 Muscarinic Agonist ML-007C-MA for Schizophrenia Treatment
第 1 页,共 504 页
上一页
下一页